These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Resection for advanced pancreatic cancer following multimodal therapy]. Kleeff J; Stöß C; Yip V; Knoefel WT Chirurg; 2016 May; 87(5):406-12. PubMed ID: 27138271 [TBL] [Abstract][Full Text] [Related]
44. How to define and manage borderline resectable pancreatic cancer. Papavasiliou P; Chun YS; Hoffman JP Surg Clin North Am; 2013 Jun; 93(3):663-74. PubMed ID: 23632151 [TBL] [Abstract][Full Text] [Related]
45. Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. Miura JT; Krepline AN; George B; Ritch PS; Erickson BA; Johnston FM; Oshima K; Christians KK; Evans DB; Tsai S Surgery; 2015 Dec; 158(6):1545-55. PubMed ID: 26243342 [TBL] [Abstract][Full Text] [Related]
47. [CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA]. Van Daele D; Martinive P; Loly C; Polus M; Collignon J; Gast P; Louis E; Van Laethem JL Rev Med Liege; 2015 Nov; 70(11):540-5. PubMed ID: 26738264 [TBL] [Abstract][Full Text] [Related]